treatment

Plasma exchange therapy is gaining popularity as a wellness trend among longevity-seekers.The procedure involves replacing plasma to remove toxins, typically from specific health conditions.There’s limited evidence it can boost longevity or benefit otherwise healthy people. A medical treatment used for health emergencies and autoimmune disorders is becoming the hot new…

Geron (NASDAQ:) Corporation (NASDAQ: GERN), a biopharmaceutical company, has reported encouraging early launch results for its new drug RYTELO, designed to treat lower-risk myelodysplastic syndromes (MDS). As of July 31, 2024, around 160 patients have been treated with RYTELO. The company has successfully penetrated 60% of the top decile 1-4…

In a recent earnings call, Curis Inc. (NASDAQ:), a biotechnology company specializing in cancer treatments, provided a business update for the second quarter of 2024. President and CEO Jim Dentzer outlined significant progress in the company’s TakeAim Lymphoma and TakeAim Leukemia studies, focusing on the development of their drug emavusertib.…

POTOMAC, Md. – IGC Pharma Inc. (NYSE American: IGC) has shared interim results from its Phase 2 clinical trial of IGC-AD1, which is being investigated as a treatment for agitation in patients with Alzheimer’s disease. The data indicates a statistically significant reduction in agitation levels compared to a placebo. The…